Dermatology is facing a worsening scarcity of providers, especially since the onset of the COVID-19 pandemic. With lengthening waiting periods for skin cancer screening examinations, there is a distinct need for alternatives to in-person evaluation. Delayed diagnosis is associated with poorer outcomes, especially in melanoma. Teledermatology has the potential to prevent the increased morbidity and mortality associated with late-stage diagnosis, especially when utilized with dermoscopy. In the literature, this novel field of “teledermoscopy” has exhibited accuracy and reliability comparable to face-to-face visits and is a promising alternative intervention for those who require triaging or for patients who are unable to access in-person care (rural, underserved populations). Although the early data is promising, formal guidelines for acquisition and interpretation of dermatoscopic images need to be established before wider implementation is possible. With standardization, use at-home or in in primary care offices will with such standardization, may relieve some of the pressure on an overburdened dermatologic care system and help patients who require urgent care to be seen more expediently.
Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Network Open. 2021;4(4):e214708.
2.
Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatology. 2022;158(5):495.
3.
Skin cancer facts & statistics. 2022;
4.
Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011. American Journal of Preventive Medicine. 2015;48(2):183–7.
5.
Guy GP, Ekwueme DU, Tangka FK, Richardson LC. Melanoma Treatment Costs. American Journal of Preventive Medicine. 2012;43(5):537–45.
6.
Leachman SA, Cassidy PB, Chen SC, Curiel C, Geller A, Gareau D, et al. Methods of Melanoma Detection. Cancer Treatment and Research. Springer International Publishing; 2015. p. 51–105.
7.
Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, et al. Behavioral Counseling to Prevent Skin Cancer. JAMA. 2018;319(11):1134.
8.
King SC, Chen S. Analyzing the Cost of Preventing Nonmelanoma Skin Cancer. Journal of Investigative Dermatology. 2009;129(12):2745–6.
9.
Akamine KL, Gustafson CJ, Davis SA, Levender MM, Feldman SR. Trends in Sunscreen Recommendation Among US Physicians. JAMA Dermatology. 2014;150(1):51.
10.
Coustasse A, Sarkar R, Abodunde B, Metzger BJ, Slater CM. Use of Teledermatology to Improve Dermatological Access in Rural Areas. Telemedicine and e-Health. 2019;25(11):1022–32.
11.
Zakaria A, Maurer T, Su G, Amerson E. Impact of teledermatology on the accessibility and efficiency of dermatology care in an urban safety-net hospital: A pre-post analysis. Journal of the American Academy of Dermatology. 2019;81(6):1446–52.
12.
Lange M, Plorina E, Lihacova I, Derjabo A, Spigulis J. Skin cancer screening -better safe than sorry. SHS Web Conf. 2020;
13.
Lange M, Plorina EV, Lihacova I, Derjabo A, Spigulis J. Skin cancer screening – better safe than sorry. SHS Web of Conferences. 2020;85:02003.
14.
Kimball AB, Resneck JS. The US dermatology workforce: A specialty remains in shortage. Journal of the American Academy of Dermatology. 2008;59(5):741–5.
15.
Cortez JL, Fadadu RP, Konda S, Grimes B, Wei ML. Disparities in access for melanoma screening by region, specialty, and insurance: A cross-sectional audit study. JAAD International. 2022;7:78–85.
16.
Delans K. Teledermoscopy – An Emerging Technology for Skin Cancer Detection. Telehealth and Medicine Today. 2023;8(1).
17.
Suneja T, Smith ED, Chen GJ, Zipperstein KJ, Fleischer, Jr AB, Feldman SR. Waiting Times to See a Dermatologist Are Perceived as Too Long by Dermatologists. Archives of Dermatology. 2001;137(10).
18.
Narayanamurthy V, Padmapriya P, Noorasafrin A, Pooja B, Hema K, Firus Khan AY, et al. Skin cancer detection using non-invasive techniques. RSC Advances. 2018;8(49):28095–130.
19.
Lamm R, Lyons W, So W, Willis AI. Advanced‐Stage Melanoma at Presentation Following the Peak of the Pandemic: A COVID‐19 Cancer Canary in a Coal Mine. World Journal of Surgery. 2022;46(8):1820–5.
20.
Greaney L, King I. Dermoscopy – Dermatologists only? British Journal of Oral and Maxillofacial Surgery. 2017;55(10):e64.
21.
Chen YA, Seiverling E, Rill J. Analysis of dermoscopy teaching modalities in United States dermatology residency programs. Dermatology Practical & Conceptual. 2017;7(3):38–43.
22.
Errichetti E, Stinco G. The practical usefulness of dermoscopy in general dermatology. G Ital Dermatol Venereol. 2015;(1–2):1–14.
23.
Hoorens I, Vossaert K, Lanssens S, Dierckxsens L, Argenziano G, Brochez L. Value of Dermoscopy in a Population-Based Screening Sample by Dermatologists. Dermatology Practical & Conceptual. 2019;200–6.
24.
Dinnes J, Deeks JJ, Chuchu N, Ferrante di Ruffano L, Matin RN, Thomson DR, et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database of Systematic Reviews. 2018;2018(12).
25.
Williams NM, Marghoob AA, Seiverling E, Usatine R, Tsang D, Jaimes N. Perspectives on Dermoscopy in the Primary Care Setting. The Journal of the American Board of Family Medicine. 2020;33(6):1022–4.
26.
Jones O, Jurascheck L, van Melle M, Hickman S, Burrows N, Hall P, et al. Dermoscopy for melanoma detection and triage in primary care: a systematic review. BMJ Open. 2019;9(8):e027529.
27.
Hadeler E, Gitlow H, Nouri K. Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: a systematic review. Archives of Dermatological Research. 2020;313(4):205–15.
28.
Maddukuri S, Patel J, Lipoff JB. Teledermatology Addressing Disparities in Health Care Access: a Review. Current Dermatology Reports. 2021;10(2):40–7.
29.
Giavina Bianchi M, Santos A, Cordioli E. Dermatologists’ perceptions on the utility and limitations of teledermatology after examining 55,000 lesions. Journal of Telemedicine and Telecare. 2019;27(3):166–73.
30.
Singh SR, Meka AP, Nguyen G, Tejasvi T. Teledermoscopy for Teledermatology. Current Dermatology Reports. 2016;5(2):71–6.
31.
Dovigi E, Kwok EYL, English JC. A Framework-Driven Systematic Review of the Barriers and Facilitators to Teledermatology Implementation. Current Dermatology Reports. 2020;9(4):353–61.
32.
Raef H, Hourihan M, MacDonald JM, Lewis J, Seiverling EV. Addressing geographic disparities in dermatology through virtual educational outreach. SKIN The Journal of Cutaneous Medicine. 2022;6(1):36–40.
33.
Marson J, Litchman G, Rigel D. Differential Impact of COVID-19 on Urban Versus Rural Dermatologic Practice Logistics and Recovery: A Cross-Sectional Investigation of the First Wave. SKIN The Journal of Cutaneous Medicine. 2021;5(2):118–24.
34.
Osborne N, Muzumdar S, Mostow E, Feng H. Rural dermatology: statistical measures and epidemiology. 2021;
35.
Tan E, Yung A, Jameson M, Oakley A, Rademaker M. Successful triage of patients referred to a skin lesion clinic using teledermoscopy (IMAGE IT trial). British Journal of Dermatology. 2010;162(4):803–11.
36.
Chuchu N, Dinnes J, Takwoingi Y, Matin RN, Bayliss SE, Davenport C, et al. Teledermatology for diagnosing skin cancer in adults. Cochrane Database of Systematic Reviews. 2018;2018(12).
37.
Kong F, Horsham C, Rayner J, Simunovic M, O’Hara M, Soyer HP, et al. Consumer Preferences for Skin Cancer Screening Using Mobile Teledermoscopy: A Qualitative Study. Dermatology. 2020;236(2):97–104.
38.
Horsham C, Snoswell C, Vagenas D, Loescher LJ, Gillespie N, Soyer HP, et al. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care. Dermatology. 2020;236(2):90–6.
39.
Bruce A, Mallow J, Theeke L. The use of teledermoscopy in the accurate identification of cancerous skin lesions in the adult population: a systematic review. J Telemed Telecare. 2018;
40.
Bruce AF, Mallow JA, Theeke LA. The use of teledermoscopy in the accurate identification of cancerous skin lesions in the adult population: A systematic review. Journal of Telemedicine and Telecare. 2017;24(2):75–83.
41.
Gilling S, Mortz C, Vestergaard T. Patient Satisfaction and Expectations Regarding Mobile Teledermoscopy in General Practice for Diagnosis of Non-melanoma Skin Cancer and Malignant Melanoma. Acta Dermato Venereologica. 2020;100(8):adv00117-7.
42.
Uppal SK, Beer J, Hadeler E, Gitlow H, Nouri K. The clinical utility of teledermoscopy in the era of telemedicine. Dermatologic Therapy. 2021;34(2).
43.
Lee K, Finnane A, Soyer HP. Recent trends in teledermatology and teledermoscopy. Dermatology Practical & Conceptual. 2018;8(3):214–23.
44.
Hue L, Makhloufi S, Sall N’Diaye P, Blanchet‐Bardon C, Sulimovic L, Pomykala F, et al. Real‐time mobile teledermoscopy for skin cancer screening targeting an agricultural population: an experiment on 289 patients in France. Journal of the European Academy of Dermatology and Venereology. 2015;30(1):20–4.
45.
Marwaha SS, Fevrier H, Alexeeff S, Crowley E, Haiman M, Pham N, et al. Comparative effectiveness study of face-to-face and teledermatology workflows for diagnosing skin cancer. Journal of the American Academy of Dermatology. 2019;81(5):1099–106.
46.
Börve A, Gyllencreutz J, Terstappen K, Backman E, Aldenbratt A, Danielsson M, et al. Smartphone Teledermoscopy Referrals: A Novel Process for Improved Triage of Skin Cancer Patients. Acta Dermato Venereologica. 2015;95(2):186–90.
47.
Piccolo D, Smolle J, Argenziano G, Wolf IH, Braun R, Cerroni L, et al. Teledermoscopy - results of a multicentre study on 43 pigmented skin lesions. Journal of Telemedicine and Telecare. 2000;6(3):132–7.
48.
Vestergaard T, Prasad SC, Schuster A, Laurinaviciene R, Andersen MK, Bygum A. Diagnostic accuracy and interobserver concordance: teledermoscopy of 600 suspicious skin lesions in Southern Denmark. Journal of the European Academy of Dermatology and Venereology. 2020;34(7):1601–8.
49.
Snoswell CL, Caffery LJ, Whitty JA, Soyer HP, Gordon LG. Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia. JAMA Dermatology. 2018;154(6):694.
50.
Acharya P, Mathur M. Use of a mobile application to perform videodermatoscopy with a handheld dermatoscope. Journal of the American Academy of Dermatology. 2021;84(3):e139–40.
51.
Gupta S, Aggarwal K, Yadav A, Gujrathi A. Low-cost video dermatoscope using an inexpensive clip-on lens. JAAD International. 2020;1(1):9–10.
52.
Finnane A, Dallest K, Janda M, Soyer HP. Teledermatology for the Diagnosis and Management of Skin Cancer. JAMA Dermatology. 2017;153(3):319.
53.
Janda M, Loescher LJ, Banan P, Horsham C, Soyer HP. Lesion Selection by Melanoma High-Risk Consumers During Skin Self-examination Using Mobile Teledermoscopy. JAMA Dermatology. 2014;150(6):656.
54.
Koh U, Horsham C, Soyer HP, Loescher LJ, Gillespie N, Vagenas D, et al. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma. Dermatology. 2018;235(1):4–10.
55.
Deda LC, Goldberg RH, Jamerson TA, Lee I, Tejasvi T. Dermoscopy practice guidelines for use in telemedicine. npj Digital Medicine. 2022;5(1).
56.
Combalia M, Codella N, Rotemberg V, Carrera C, Dusza S, Gutman D, et al. Validation of artificial intelligence prediction models for skin cancer diagnosis using dermoscopy images: the 2019 International Skin Imaging Collaboration Grand Challenge. The Lancet Digital Health. 2022;4(5):e330–9.
57.
Stiff KM, Franklin MJ, Zhou Y, Madabhushi A, Knackstedt TJ. Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications. Pigment Cell & Melanoma Research. 2022;35(2):203–11.
58.
Agbai ON, Buster K, Sanchez M, Hernandez C, Kundu RV, Chiu M, et al. Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public. Journal of the American Academy of Dermatology. 2014;70(4):748–62.
59.
Sierro TJ, Blumenthal LY, Hekmatjah J, Chat VS, Kassardjian AA, Read C, et al. Differences in health care resource utilization and costs for keratinocyte carcinoma among racioethnic groups: A population-based study. Journal of the American Academy of Dermatology. 2022;86(2):373–8.
60.
Brady J, Kashlan R, Ruterbusch J, Farshchian M, Moossavi M. Racial Disparities in Patients with Melanoma: A Multivariate Survival Analysis. Clinical, Cosmetic and Investigational Dermatology. 2021;Volume 14:547–50.
61.
Hogue L, Harvey VM. Basal Cell Carcinoma, Squamous Cell Carcinoma, and Cutaneous Melanoma in Skin of Color Patients. Dermatologic Clinics. 2019;37(4):519–26.
62.
Pangti R, Mathur J, Chouhan V, Kumar S, Rajput L, Shah S, et al. A machine learning‐based, decision support, mobile phone application for diagnosis of common dermatological diseases. Journal of the European Academy of Dermatology and Venereology. 2020;35(2):536–45.
63.
Daneshjou R, Vodrahalli K, Novoa RA, Jenkins M, Liang W, Rotemberg V, et al. Disparities in dermatology AI performance on a diverse, curated clinical image set. Science Advances. 2022;8(32).
64.
Groh M, Harris C, Soenksen L, Lau F, Han R, Kim A. Evaluating deep neural networks trained on clinical images in dermatology with the fitzpatrick 17k dataset. 2021;1820–8.
65.
Tschandl P, Rosendahl C, Kittler H. The HAM10000 dataset, a large collection of multi-source dermatoscopic images of common pigmented skin lesions. Scientific Data. 2018;5(1).
66.
Ouellette S, Rao B. Usefulness of smartphones in dermatology: a US-based review. Int J Environ Res Public Health. 2022;
67.
Ouellette S, Rao BK. Usefulness of Smartphones in Dermatology: A US-Based Review. International Journal of Environmental Research and Public Health. 2022;19(6):3553.
68.
Walocko FM, Tejasvi T. Teledermatology Applications in Skin Cancer Diagnosis. Dermatologic Clinics. 2017;35(4):559–63.
69.
Zink A, Kolbinger A, Leibl M, Léon Suarez I, Gloning J, Merkel C, et al. Teledermatoskopie mittels Smartphone. Der Hautarzt. 2017;68(11):890–5.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
